Hutch News
Fred Hutch Statement Regarding the FDA Action on CTL019 Immunotherapy
Fred Hutch expert comments on FDA approval of new Novartis immunotherapy drug CTL019 — August 30, 2017
Promising results in trial of engineered T cells in high-risk leukemia
High response rates to experimental immunotherapy in patients with treatment-resistant chronic lymphocytic leukemia
Good News: GeekWire Award Finalists include Bezos Family Immunotherapy Clinic and Nohla Therapeutics, among others
Celebrating faculty and staff achievements
Bezos family gives $35 million to Fred Hutch
Transformative investment will be used to hire more world-class researchers to launch innovative approaches to curing cancer, said Fred Hutch President and Director Gilliland
Bezos family gives $35 million to Fred Hutch
‘What we are really giving is the gift of time’; funds will be invested in more world-class faculty to speed cures for cancer patients
Good News at Fred Hutch
Celebrating faculty and staff achievements
‘A place where miracles happen’: Opening of Bezos Family Immunotherapy Clinic highlights patient-focused science
Research symposium and ribbon cutting celebrates first-of-its-kind facility for experimental immunotherapies
'A place where miracles happen': Opening of Bezos Family Immunotherapy Clinic highlights patient-focused science
Research symposium and ribbon cutting celebrates first-of-its-kind facility for experimental immunotherapies
Good News: Malik and Bloom win ASM awards; pilot project funded by Bezos family aims to create personalized anticancer vaccines
Celebrating faculty and staff achievements
Cost of survival: Coping with treatment complications beyond the cure
Treatment complications can impact lives for years after cure but some cancers survivors are reluctant to reveal their pain
Fred Hutch opens first-of-its kind Bezos Family Immunotherapy Clinic
Clinic will allow researchers to conduct twice as many immunotherapy trials, enable intensive patient monitoring to improve experimental therapies